HomeXLO • NASDAQ
add
Xilio Therapeutics Inc
Previous close
$0.80
Day range
$0.73 - $0.81
Year range
$0.49 - $2.89
Market cap
34.24M USD
Avg Volume
160.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 2.36M | — |
Operating expense | 17.03M | -15.34% |
Net income | -13.92M | 28.05% |
Net profit margin | -590.79 | — |
Earnings per share | -0.24 | 65.63% |
EBITDA | -14.23M | 27.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 74.95M | -0.58% |
Total assets | 89.87M | -2.69% |
Total liabilities | 56.46M | 125.99% |
Total equity | 33.42M | — |
Shares outstanding | 43.95M | — |
Price to book | 1.05 | — |
Return on assets | -42.54% | — |
Return on capital | -95.48% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -13.92M | 28.05% |
Cash from operations | 19.95M | 220.39% |
Cash from investing | -21.00K | 93.35% |
Cash from financing | 20.04M | 2,120.46% |
Net change in cash | 39.98M | 323.55% |
Free cash flow | 31.95M | 408.91% |
About
Founded
2016
Headquarters
Website
Employees
56